| FXAIX | GQEPX | FXAIX / GQEPX | |
| Total Expense Ratio | 0.01 | 0.70 | 2% |
| Annual Report Gross Expense Ratio | 0.01 | 0.71 | 2% |
| Fund Existence | 15 years | 8 years | - |
| Gain YTD | 11.562 | 8.142 | 142% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 832B | 2.75B | 30,244% |
| Annual Yield % from dividends | 1.03 | 2.21 | 47% |
| Returns for 1 year | 29.57 | 1.80 | 1,644% |
| Returns for 3 years | 84.73 | 35.61 | 238% |
| Returns for 5 years | 94.64 | 47.88 | 198% |
| Returns for 10 years | 301.46 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VOT | 304.49 | 3.03 | +1.01% |
| Vanguard Mid-Cap Growth ETF | |||
| EYLD | 47.93 | 0.28 | +0.59% |
| Cambria Emerging Shareholder Yield ETF | |||
| ZAPR | 26.61 | 0.02 | +0.08% |
| Innovator Equity Dfnd Prt ETF -1 Yr Apr | |||
| DTRE | 43.28 | N/A | N/A |
| First Trust Alerian Dsrupt Tech RE ETF | |||
| SBIO | 50.31 | -2.50 | -4.73% |
| ALPS Medical Breakthroughs ETF | |||